← Back to Research Radar
Academic Publication Academic Publication

Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

242
Citations
August 1, 2024
Published Date

Research Abstract & Technology Focus

No abstract provided for this literature.
effectiveness impact universal prophylaxis nirsevimab infants
Read Full Literature

AI Semantic Synergy Context

Connecting this academic literature to real-world market discussions and products.

crossref.org › academic paper
98%
🔥

Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

No description provided.
openalex.org › research concept
0%

Immune Suppression and Antimicrobial Resistance in Hospitalised HIV Patients: Evidence from Free State and Northern Cape Hospitals.

Background: Globally, studies has shown that microorganism infections are responsible for high rate of morbidity and mortality among immune-compromised patients. Such an increase is being observed ...
roipad.com › trend story
0%

Intranasal DNA nanocarrier vaccines with surface-patterned antigens enhance efficacy against respiratory syncytial virus

DNA-based nanocarrier vaccines with optimized surface antigen arrangements induce mucosal, humoral and cellular immunity and are effective intranasal vaccines for diverse respiratory diseases.
roipad.com › trend story
0%

Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial

In a randomized open-label trial, Wei-Xiang Qi and colleagues investigate the feasibility of dose-reduced thoracic radiotherapy to mitigate treatment related toxicities while preserving oncological...
roipad.com › trend story
0%

Implementation bottlenecks of near point of care HIV viral load monitoring for children and young people in Tanzania: A Qualitative Study

Background Near point-of-care (n)POC Human Immunodeficiency Virus (HIV) viral load (VL) monitoring, consisting of VL testing in laboratories close to HIV treatment facilities, improves turnaround t...

Frequently Asked Questions (FAQ)

Curated market intelligence mapped to this research.

What is the core focus of the research titled 'Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study'?

This literature focuses on:

Are there open-source GitHub repositories related to Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study?

Yes, open-source projects like jackwener/opencli (Make Any Website & Tool Your CLI. A universal CLI Hub and AI-native runtime. Transform any website, Electron app, or local binary into a standardiz...) are actively building upon these concepts.

Which startups are commercializing the technology behind Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study?

Products like FileFlan are bringing this to market. Their focus is: Instant private universal file sharing.

What other academic literature is closely related to 'Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study'?

Yes, highly correlated activity was mapped. An entry titled 'Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study' discusses this: No description provided.

Are there commercial applications of 'Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study' in market news publications?

Yes, highly correlated activity was mapped. An entry titled 'Intranasal DNA nanocarrier vaccines with surface-patterned antigens enhance efficacy against respiratory syncytial virus' discusses this: DNA-based nanocarrier vaccines with optimized surface antigen arrangements induce mucosal, humoral and cellular immunity and are effective intranas...

Cite this Market Intelligence Report

Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.

Commercial Realization

Startups and Open Source tools heavily associated with the concepts explored in this paper.

Associated Media Narrative